Reproductive health

Femasys Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference

Retrieved on: 
Monday, November 21, 2022
Reproductive health, Tubing (recreation), Webcast, Infertility, SoHo, Manhattan, Medical imaging

SoHo Track | Hubbard 1, 5thFloor

Key Points: 
  • SoHo Track | Hubbard 1, 5thFloor
    The Femasys management team will also participate in one-on-one meetings during the event.
  • Investors interested in meeting with Company management should contact their Piper Sandler representative.
  • Its two lead product candidates are FemBloc permanent birth control and FemaSeed localized directional insemination for infertility.
  • The Companys product for fallopian tube assessment by ultrasound, FemVue, is currently marketed in the United States.

Grassroot Soccer World AIDS Day Gala Set for December 1 in New York City

Retrieved on: 
Wednesday, November 16, 2022
COVID-19, Mental health, Coach, Athlete, Adolescence, Organization, HIV/AIDS, Reproductive health, Survivor, Partnership, Malaria, Methembe Ndlovu, GRS, Chelsea F.C., Movement, Major League Soccer, Angel City FC, Ziegfeld Theatre (1969), Gender, AIDS, Icarus FC, Health, Research, School-related gender-based violence in Vietnam, HIV, Grassroot Soccer, Nightclub, Sport, Birth control

New York, New York, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Grassroot Soccer, the renowned international adolescent health organization celebrating its 20th anniversary, will host its annual World AIDS Day Gala on Thursday, December 1 at the legendary Ziegfeld Ballroom in New York City.

Key Points: 
  • New York, New York, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Grassroot Soccer, the renowned international adolescent health organization celebrating its 20th anniversary, will host its annual World AIDS Day Gala on Thursday, December 1 at the legendary Ziegfeld Ballroom in New York City.
  • It also celebrates the Grassroot Soccer Coaches who are making a difference for so many young people.
  • Grassroot Soccers World AIDS Day Gala is the organization's biggest fundraiser of the year, raising over $1.5M to support its global adolescent health programs.
  • Founded in 1988, World AIDS Day was the first ever global health day.

Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference

Retrieved on: 
Thursday, November 17, 2022
Oncology, Health, Infectious Diseases, Health Technology, Genetics, Pharmaceutical, Biotechnology, Pathology, Conference, Reproductive health, Cancer, Precision medicine, Piper Sandler Companies, Genetics, Therapy, Degenerative disease, Battle of Saint-Fulgent, Webcast, Health, Pharmaceutical industry

Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based genetic testing and therapeutics company focused on transforming patient care in oncology, infectious and rare diseases, reproductive health, and pathology, today announced that members of its management team are scheduled to participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022.

Key Points: 
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based genetic testing and therapeutics company focused on transforming patient care in oncology, infectious and rare diseases, reproductive health, and pathology, today announced that members of its management team are scheduled to participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022.
  • These representatives of the company will conduct a presentation beginning at approximately 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time).
  • A live webcast of the session will be available on the Investor Relations section of the Fulgent Genetics website at ir.fulgentgenetics.com .
  • Fulgent is a technology-based genetic testing and therapeutics company focused on transforming patient care in oncology, infectious and rare diseases, reproductive health, and pathology.

Next-generation Sequencing Market Anticipated to be worth $14.8 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Thursday, November 24, 2022
Automation, Incidence, Investment, Biology, Hospital, Workflow, Consumer, Biotechnology, Infection, Revenue, Thermo Fisher Scientific, Name, Oncology, Agilent Technologies, DNA, Cloud computing, Oxford Nanopore Technologies, Projection, Reproductive health, US, Disorder, Cancer, USD, Research, Pacific Biosciences, Vaccine, Movement, Growth, Genetic testing, RNA, COVID-19, Sanger, NGS, Diagnosis, SAN, Data analysis, Gene, Medical imaging, Fine chemical, Pharmaceutical industry, Illumina

Key industry Insights & Findings from the report:

Key Points: 
  • Key industry Insights & Findings from the report:
    NGS is more economical in comparison to the conventional Sanger sequencing technology, while also offering a higher DNA sequencing throughput.
  • The oncology application segment was the most significant market contributor in terms of revenue in 2021.
  • Based on the workflow, the sequencing segment accounted for the highest market share in 2021, on account of it being the most critical workflow phase.
  • Grand View Research has segmented the global Next-generation sequencing market based on technology, workflow, application, end-use, and region:
    Next-generation Sequencing Market - Technology Outlook (Revenue, USD Million, 2018 - 2030)

Feminine Wipes Global Market Report 2022 Featuring Major Players - Albaad Massuot Yitzhak, Corman, LA Fresh Group, Guy & O'Neill, & Healthy Hoohoo - ResearchAndMarkets.com

Retrieved on: 
Monday, November 14, 2022
Medical Supplies, Retail, Health, Consumer, Other Retail, Women, Supermarket, Hygiene, Education, World Health Organization, Health minister, Wool, Reproductive health, Female, Acquisition, Woman, Pharmacy, Growth, Menstruation, Public health, Aditi, Private company limited by shares, Infection, Time-invariant system, United Nations, City, School, Health, First Nations in Ontario, Cosmetics, Birth control

The "Feminine Wipes Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Feminine Wipes Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The distribution channels of feminine wipes include supermarkets and hypermarkets, convenience stores, pharmacies and drugstores, and online, and other distribution channels.
  • The regions covered in the feminine wipes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The countries covered in the feminine wipes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns

Retrieved on: 
Monday, November 14, 2022
FDA, Other Health, Pharmaceutical, General Health, Medical Devices, Parenting, Children, Baby, Maternity, Family, Science, Biotechnology, Consumer, Other Science, Health, Research, Automation, FDA, Brainstem, Spinal muscular atrophy, Marketing, SCID, ESG, Food, Accreditation, Laboratory, Government, PerkinElmer, CE, PCR, DNA, Reproductive health, NYSE, Science, Motor neuron, SMA, Infant, Spinal cord, Software, Safety, Fundamental Analysis Software, Informatics, IVD, Birth, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, PKI, Degenerative disease, Inherited disorders of trafficking, Muscle weakness, Atrophy, Pharmaceutical industry

This is the first FDA authorized assay for SMA screening in newborns in the United States and is part of the Companys broader EONIS Platform .

Key Points: 
  • This is the first FDA authorized assay for SMA screening in newborns in the United States and is part of the Companys broader EONIS Platform .
  • This authorization is a major milestone for newborn screening in the United States.
  • Other components of the platform include the EONIS DNA Extraction kit and EONIS Analysis Software.
  • As the global leader in newborn screening, PerkinElmer offers solutions to help identify more than 50 congenital disorders.

Femtech Market to Witness CAGR of 12% (2022-2028) Due to Increasing Digital Health Solutions Worldwide | UnivDatos Market Insights

Retrieved on: 
Friday, November 18, 2022
Flo, Fertility clinic, Growth, Health, Woman, Reproductive health, Pregnancy, HeRAMS, Nursing, Device, COVID-19, General Healthcare Group, Shock, Smartphone, Prevalence, Wilford Hall Ambulatory Surgical Center, Natural Cycles, Medical device, Video game, NOIDA, Software, Femtech

The femtech market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The femtech market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • The femtech market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the femtech market at the global and regional levels.
  • The femtech market is expected to grow on account of the growing adoption of digital health solutions, increasing digital literacy and escalating smartphone penetration across the world.

Femtech Market to Witness CAGR of 12% (2022-2028) Due to Increasing Digital Health Solutions Worldwide | UnivDatos Market Insights

Retrieved on: 
Friday, November 18, 2022
Flo, Fertility clinic, Growth, Health, Woman, Reproductive health, Pregnancy, HeRAMS, Nursing, Device, COVID-19, General Healthcare Group, Shock, Smartphone, Prevalence, Wilford Hall Ambulatory Surgical Center, Natural Cycles, Medical device, Video game, NOIDA, Software, Femtech

The femtech market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The femtech market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • The femtech market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the femtech market at the global and regional levels.
  • The femtech market is expected to grow on account of the growing adoption of digital health solutions, increasing digital literacy and escalating smartphone penetration across the world.

Illumina To Webcast Upcoming Investor Conferences

Retrieved on: 
Tuesday, November 15, 2022
SAN, Genome, Conference, Health, Illumina, Inc., YouTube, ISI, Piper Sandler Companies, Research, DNA, Reproductive health, NASDAQ, Agriculture, Illumina, Facebook

SAN DIEGO, Nov. 15, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:

Key Points: 
  • SAN DIEGO, Nov. 15, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:
    Evercore ISI HealthCONx Conference on November 29, 2022
    Piper Sandler 34th Annual Healthcare Conference on November 30, 2022
    The webcasts can be accessed through the Investor Info section of Illumina's website at investor.illumina.com .
  • A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
  • Illumina is improving human health by unlocking the power of the genome.
  • Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.

A NOT SO HAPPY HOLIDAY: THE STEVE FUND OFFERS USEFUL TIPS TO YOUNG PEOPLE OF COLOR AND THEIR FAMILIES STRUGGLING WITH SEASONAL STRESS, ANXIETY

Retrieved on: 
Tuesday, November 15, 2022
University, Anxiety, Doctor of Philosophy, Suicide, Student, Hearing, Mental health, TSF, View, Holiday, Multimedia, Reproductive health, Color, Trans Lifeline, STEVE, Grief, Medicine

NEW YORK, Nov. 15, 2022 /PRNewswire/ -- The Steve Fund (TSF), the nation's leading nonprofit organization supporting the mental health and wellbeing of young people of color, is launching new mental health and wellness tips to help combat the stress and anxiety that often affects communities of color during the holiday season.

Key Points: 
  • As the holiday season approaches, many face the added stress of family dynamics and mental health challenges over Thanksgiving, Christmas and Kwanzaa.
  • "We are keenly aware of the stressors many Black and Brown students, their families and LGBTQIA+ youth of color will face over the next few weeks.
  • For those experiencing more severe symptoms, text STEVE to 74141 or call/text 988 for the Suicide & Crisis Hotline.
  • In Canada, 877-330-6366
    The Steve Fund is the nation's leading organization focused on supporting the mental health and wellbeing of young people of color.